Results 201 to 210 of about 456,204 (268)
Immunotherapy for pediatric solid tumors: overcoming biological barriers through rational multimodal combinations. [PDF]
Fatahichegeni M +4 more
europepmc +1 more source
The hyperactivation of PI3K/AKT signaling in PTEN wild‐type triple‐negative breast cancer represents a clinical paradox. We delineate a novel post‐translational regulatory axis wherein the oncogene TSPYL5 competitively antagonizes the deubiquitinase USP10.
Jiaying Shi +8 more
wiley +1 more source
A Bioinspired Approach to Next-Generation Vaccines in Solid Tumors with Engineered Cell Membranes. [PDF]
Zhang W, Chen M, Huang X.
europepmc +1 more source
ABSTRACT Mast cells (MCs), key innate immune sentinels at the host–environment interface, serve as primary responders to invading pathogens. However, their specific contribution to host defense against cutaneous Candida albicans (C. albicans) infection and their synergy with other immune and non‐immune cells remain poorly understood. Here, we show that
Yan Yuan +12 more
wiley +1 more source
Adapter-based allogeneic CAR T cells to overcome antigen escape in solid tumors. [PDF]
Pham PQ, Sodji QH.
europepmc +1 more source
FGF13 is upregulated in DRG neurons of PIPNP model mice. DRG neuron‐specific knockout of FGF13 ameliorates PIPNP symptoms. Mechanistically, FGF13 potentiates microtubule detyrosination by promoting VASH1 binding to microtubules. FGF13 knockout suppresses VASH1‐mediated microtubule detyrosination and promotes α‐tubulin tyrosination.
Yiming Dong +10 more
wiley +1 more source
Optimizing next-generation CAR-macrophages against solid tumors: challenges and potential strategies. [PDF]
Chen Y +9 more
europepmc +1 more source
Efficacy and safety of tocilizumab for neoplastic fever in patients with advanced solid tumors: a multicenter retrospective study. [PDF]
Yan Y +12 more
europepmc +1 more source
CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead. [PDF]
Al Shaer NSH +6 more
europepmc +1 more source
Obstacles and improvement strategies for CAR-T cell therapy in solid tumors. [PDF]
Luo Z +9 more
europepmc +1 more source

